Optimal use of Rapid Diagnostics in Infection Control and Prevention

Clinical laboratories have implemented rapid diagnostic tests (RDTs) for the identification of bacterial pathogens, with subsequent improvements in antimicrobial stewardship, but these tests may also have a role in infection prevention. Early identification of pathogens by RDTs should allow faster implementation of infection prevention strategies with the goal of reducing transmission. In this review, we assess the use of RDTs as an infection control tool by exploring their role in screening, as well as diagnosis, of methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant gram-negative organisms, Clostridium difficile, and Mycobacterium tuberculosis. This assessment highlights the fact that implementation of RDTs to improve infection prevention will require ongoing collaboration between clinical laboratory personnel, infection prevention departments, and clinicians.